ascopubs.org

Infusional CHOP Chemotherapy (CVAD) With or Without Chemosensitizers Offers No Advantage Over Standard CHOP Therapy in the Treatment of Lymphoma: A Southwest Oncology Group Study

Results of Intensive Chemotherapy Followed by Hematopoietic Stem-Cell Rescue in 22 Patients With Refractory or Recurrent Primary CNS Lymphoma or Intraocular Lymphoma PURPOSE: Two phase II studies were ...
Healio

VIDEO: Evolution of hyper-CVAD in ALL

Please provide your email address to receive an email when new articles are posted on . In this video, Lori Muffly, MD, MS, discussed a presentation from the Society of Hematologic Oncology Annual ...
Healio

Adding nelarabine to hyper-CVAD appears safe, effective in adults with T-ALL

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — The addition of nelarabine to a standard hyper-CVAD regimen demonstrated durable overall response ...
Nature

The combination of hyper-CVAD plus nelarabine as frontline therapy in adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma: MD Anderson Cancer Center experience

Forty patients with T-ALL/LL were enrolled with a median age of 38 years (19–78 years). Twenty-three patients (58%) had T-ALL and 17 (43%) had LL. The performance status was ⩽2 in 36/40 (90%) patients ...
Business Wire

Cellworks Personalized Therapy Biosimulation Study Identifies Novel Biomarkers Predictive of Response in Resistance Cases of MCL

ATLANTA--(BUSINESS WIRE)--Cellworks Group, Inc., a world leader in Personalized Medicine in the key therapeutic areas of Oncology and Immunology, today announced clinical study results using the ...